Loading clinical trials...
Loading clinical trials...
This is a randomized, double-blind, placebo-controlled, 3-way crossover trial to evaluate the efficacy and safety of two different doses of inhaled TPI ASM8 administered daily for 14 days for the trea...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Syntara
NCT06979323 · Asthma
NCT06664619 · Asthma
NCT07431021 · Asthma Acute, Respiratory
NCT07383896 · Asthma, COPD
NCT07282886 · Asthma
Health Research Innovation Centre
Calgary, Alberta
Vancouver Coastal Health Research Institute
Vancouver, British Columbia
McMaster University
Hamilton, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions